Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Interplay of Histone Marks with Serine ADP-Ribosylation.

Cell reports | 2018

Serine ADP-ribosylation (Ser-ADPr) is a recently discovered protein modification that is catalyzed by PARP1 and PARP2 when in complex with the eponymous histone PARylation factor 1 (HPF1). In addition to numerous other targets, core histone tails are primary acceptors of Ser-ADPr in the DNA damage response. Here, we show that specific canonical histone marks interfere with Ser-ADPr of neighboring residues and vice versa. Most notably, acetylation, but not methylation of H3K9, is mutually exclusive with ADPr of H3S10 in vitro and in vivo. We also broaden the O-linked ADPr spectrum by providing evidence for tyrosine ADPr on HPF1 and other proteins. Finally, we facilitate wider investigations into the interplay of histone marks with Ser-ADPr by introducing a simple approach for profiling posttranslationally modified peptides. Our findings implicate Ser-ADPr as a dynamic addition to the complex interplay of modifications that shape the histone code.

Pubmed ID: 30257210 RIS Download

Research resources used in this publication

None found

Associated grants

  • Agency: Wellcome Trust, United Kingdom
  • Agency: Wellcome Trust, United Kingdom
    Id: 101794
  • Agency: Wellcome Trust, United Kingdom
    Id: 210634
  • Agency: European Research Council, International
    Id: 281739

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


ATCC (tool)

RRID:SCR_001672

Global nonprofit biological resource center (BRC) and research organization that provides biological products, technical services and educational programs to private industry, government and academic organizations. Its mission is to acquire, authenticate, preserve, develop and distribute biological materials, information, technology, intellectual property and standards for the advancement and application of scientific knowledge. The primary purpose of ATCC is to use its resources and experience as a BRC to become the world leader in standard biological reference materials management, intellectual property resource management and translational research as applied to biomaterial development, standardization and certification. ATCC characterizes cell lines, bacteria, viruses, fungi and protozoa, as well as develops and evaluates assays and techniques for validating research resources and preserving and distributing biological materials to the public and private sector research communities.

View all literature mentions

UniProt (tool)

RRID:SCR_002380

Collection of data of protein sequence and functional information. Resource for protein sequence and annotation data. Consortium for preservation of the UniProt databases: UniProt Knowledgebase (UniProtKB), UniProt Reference Clusters (UniRef), and UniProt Archive (UniParc), UniProt Proteomes. Collaboration between European Bioinformatics Institute (EMBL-EBI), SIB Swiss Institute of Bioinformatics and Protein Information Resource. Swiss-Prot is a curated subset of UniProtKB.

View all literature mentions

MaxQuant (tool)

RRID:SCR_014485

A quantitative proteomics software package for analyzing large-scale mass-spectrometric data sets. It is a set of algorithms that include peak detection and scoring of peptides, mass calibration, database searches for protein identification, protein quantification, and provides summary statistics.

View all literature mentions

U2OS (tool)

RRID:CVCL_0042

Cell line U2OS is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

HEK293T (tool)

RRID:CVCL_0063

Cell line HEK293T is a Transformed cell line with a species of origin Homo sapiens (Human)

View all literature mentions

HEK293T (tool)

RRID:CVCL_0063

Cell line HEK293T is a Transformed cell line with a species of origin Homo sapiens (Human)

View all literature mentions

PARP antibody [E102] (antibody)

RRID:AB_777101

This monoclonal targets PARP

View all literature mentions

acetyl Lysine antibody - ChIP Grade (antibody)

RRID:AB_446436

This polyclonal targets acetyl Lysine antibody - ChIP Grade

View all literature mentions

p21 (C-19) (antibody)

RRID:AB_632126

This unknown targets Raised against a peptide mapping at the carboxy terminus of human p21

View all literature mentions

Phospho-cdc2 (Tyr15) (10A11) Rabbit mAb (antibody)

RRID:AB_560953

This monoclonal targets Phospho-cdc2 (Tyr15)

View all literature mentions

PRC1 (phospho T481) antibody [EP1514Y] (antibody)

RRID:AB_944969

This monoclonal targets Human PRC1 (phospho T481)

View all literature mentions

cyclin A (H-432) (antibody)

RRID:AB_631329

This polyclonal targets CCNA2

View all literature mentions

Histone H3 (phospho S10) antibody - Mitosis Marker (antibody)

RRID:AB_304763

This polyclonal targets Histone H3 (phospho S10) antibody - Mitosis Marker

View all literature mentions

Acetylated-Lysine Antibody (antibody)

RRID:AB_331805

This polyclonal targets Acetylated-Lysine

View all literature mentions

H3K9me3-human,H3K9me3-mouse (antibody)

RRID:AB_306848

This polyclonal targets H3K9me3

View all literature mentions

Mouse Anti-Platelet/endothelial Cell Adhesion Molecule (CD31 ANTIGEN) (PECAM1) Monoclonal, Unconjugated, Clone Tld-3a12 (antibody)

RRID:AB_1060133

This monoclonal targets Platelet/endothelial Cell Adhesion Molecule (CD31 ANTIGEN) (PECAM1)

View all literature mentions

anti Phosphoserine (incl. pos. control) (antibody)

RRID:AB_1006303

This monoclonal targets anti Phosphoserine (incl. pos. control)

View all literature mentions